Publication | Closed Access

Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits

Metabolic SyndromePravastatin SodiumCoronary AtherosclerosisCardiovascular DiseaseBiochemistryMedicinePhysiologyCardiovascular PharmacologyVascular BiologyPharmacotherapyPharmacologyWhhl RabbitsAtherosclerosisDyslipidemiaOxidative StressHealth Sciences